1. Baekeland F, Lundwall L. Dropping out of treatment: a critical review. Psychological Bulletin. 1975;82:738–783. [PubMed] 2. Primm AB, Gomez MB, Tzolova-Iontchev I, Perry W, Vu HT, Crum RM. Severely mentally-ill patients with and without substance use disorders: characteristics associated with treatment attrition. Community Mental Health Journal. 2000;36:235–246. [PubMed]
3. Schafer JL, Yucel RM. Computational strategies for multivariate linear mixed-effects models with missing values. Journal of Computational and Graphical Statistics. 2002;11:437–457.
4. Yang X, Shoptaw S. Assessing missing data assumptions in longitudinal studies: an example using a smoking cessation trial. Drug and Alcohol Dependence. 2005;77:213–225. [PubMed]
5. Hubbard GM, Mardsen ME, Rachal JV, Harwood HJ, Cavanaugh ER, Ginzburg HM. Drug Abuse Treatment: National Study of Effectiveness. Chapel Hill, N.C.: University of North Carolina Press; 1989.
6. Simpson DD. Drug Treatment evaluation research in the United States. Psychology of Addictive Behaviors. 1993;7:120–128.
7. Little RJA, Rubin DB. Statistical Analysis with Missing Data. New York: Wiley; 2002.
8. Donabedian A. The quality of care: how can it be assessed? Journal of American Medical Association. 1988;260:1743–1748. [PubMed]
9. Little RJA. Modeling the drop-out mechanism in repeated-measures studies. Journal of American Statistical Association. 1995;90:1112–1121.
10. Daniels MJ, Hogan JW. Reparameterizing the pattern mixture model for sensitivity analyses under informative dropout. Biometrics. 2000;56:1241–1248. [PubMed] 11. Pauler DK, McCoy S, Moinpour C. Pattern mixture models for longitudinal quality of life studies in advanced stage disease. Statistics in Medicine. 2003;22:795–809. [PubMed] 12. Fitzmaurice GM, Laird NM, Shneyer L. An alternative parameterization of the general linear mixture model for longitudinal data with non-ignorable drop-outs. Statistics in Medicine. 2001;20:1009–1021. [PubMed]
13. Hedeker D, Gibbons RD. Application of random-effects pattern-mixture models for missing data in longitudinal studies. Psychological Methods. 1997;2:64–78.
14. Hogan JW, Laird NM. Model-based approaches to analyzing incomplete longitudinal and failure-time data. Statistics in Medicine. 1997;16:259–272. [PubMed] 15. Demirtas H, Schafer JL. On the performance of random-coefficient pattern-mixture models for non-ignorable drop-out. Statistics in Medicine. 2003;22:2553–2575. [PubMed] 16. Thijs H, Molenberghs G, Michiels B, Verbeke G, Curran D. Strategies to fit pattern-mixture models. Biostatistics. 2001;3:245–265. [PubMed]
17. Little RJA. Pattern-mixture models for multivariate incomplete data. Journal of the American Statistical Association. 1993;88:125–133.
18. Molenberghs G, Thijs H, Kenward MG, Verbeke G. Sensitivity analysis for continuous incomplete longitudinal outcomes. Statistica Neerlandica. 2003;57:112–135.
19. Roy J. Modeling longitudinal data with nonignorable dropouts using a latent dropout class model. Biometrics. 2003;59:829–836. [PubMed] 20. Roy J, Daniels M. A general class of pattern mixture models for nonignorable dropout with many possible dropout times. Biometrics. 2008 to appear. [PMC free article] [PubMed]
21. Fitzmaurice GM. Methods for handling dropouts in longitudinal clinical trials. Statistica Neerlandica. 2003;57:75–99.
22. Wu MC, Bailey KR. Estimation and comparison of changes in the presence of informative right censoring: conditional linear model. Biometrics. 1989;45:939–955. and 1990; correction, 46:889. [PubMed] 23. Hogan JW, Lin X, Herman B. Mixtures of varying coefficient models for longitudinal data with discrete or continuous non-ignorable dropout. Biometrics. 2004;60:854–864. [PMC free article] [PubMed]
24. Paddock SM. Bayesian variable selection for longitudinal substance abuse treatment data subject to informative censoring. Journal of the Royal Statistical Society, Series C (Applied Statistics) 2007;56:293–311.
25. Rubin DB. Formalizing subjective notions about the effect of nonrespondents in sample surveys. Journal of the American Statistical Association. 1977;72:538–543.
26. Kadane JB. Subjective Bayesian analysis for surveys with missing data. The Statistician. 1993;42:415–426.
27. Scharfstein DO, Daniels MJ, Robins JM. Incorporating prior beliefs about selection bias into the analysis of randomized trials with missing outcomes. Biostatistics. 2003;4:495–512. [PMC free article] [PubMed] 28. White IR, Carpenter J, Evans S, Schroter S. Eliciting and using expert opinions about dropout bias in randomized controlled trials. Journal of the Society for Clinical Trials. 2007;4:125. [PubMed]
29. Kaciroti NA, Raghunathan TE, Schork MA, Clark NM, Gong M. A Bayesian approach for clustered longitudinal ordinal outcome with nonignorable missing data: evaluation of an asthma education program. Journal of the American Statistical Association. 2006;101:435–446.
30. Lee JY, Hogan JW, Hitsman B. Sensitivity analysis and informative priors for longitudinal binary data with outcome-related dropout. Talk, Joint Statistical Meeting; Salt Lake City, Utah. 2007.
31. Freedman LS, Spiegelhalter DJ. The assessment of subjective opinion and its use in relation to stopping rules for clinical trials. The Statistician. 1983;32:153–160.
32. Chaloner K, Rhame FS. Quantifying and documenting prior beliefs in clinical trials. Statistics in Medicine. 2001;20:581–600. [PubMed]
33. Chaloner K, Church T, Matts JP, Louis TA. Graphical elicitation of a prior distribution for an AIDS clinical trial. The Statistician. 1993;42:341–353.
34. O’Hagan A. Eliciting expert beliefs in substantial practical applications. The Statistician. 1998;47:21–25.
35. Craig PS, Goldstein M, Seheult AH, Smith JA. Constructing partial prior specifications for models of complex physical systems. Journal of the Royal Statistical Society Series D (The Statistician) 1998;47:37–53.
36. Oakley J. Eliciting Gaussian process priors for complex computer codes. Journal of the Royal Statistical Society Series D (The Statistician) 2002;51:81–97.
37. Kadane JB, Wolfson LJ. Experiences in elicitation. The Statistician. 1998;47:3–19.
38. Wenzel SL. Quality of care in the therapeutic community. An NIH/NIDA-sponsored Study. 2001 5R01DA014969-03.
39. DeLeon G, Rosenthal M. Therapeutic Community. In: DuPont RL, Goldstein A, O’Donnell J, editors. Handbook on drug abuse. Washington, D.C.: U.S. GPO; 1979.
40. DeLeon G, Rosenthal MS. Treatment in Residential Therapeutic Communities. In: Karasu T, editor. Treatments of Psychiatric Disorders. Vol. 2. Washington, D.C.: American Psychiatric Press; 1989. pp. 1379–1396.
41. DeLeon G. The Therapeutic Community: Theory, Model and Method. New York, New York: Springer; 2000.
42. Hubbard RL, Craddock SG, Flynn PM, Anderson J, Etheridge RM. Overview of 1-year follow-up outcomes in the drug abuse treatment outcomes study (DATOS) Psychology of Addictive Behaviors. 1997;11:261–278.
43. Simpson DD, Joe GW, Rowan-Szal GA, Greener JM. Drug abuse treatment process components that improve retention. Journal of Substance Abuse Treatment. 1997;4:565–572. [PubMed]
44. Gerstein DR, Harwood HJ. Treating Drug Problems. Washington, D.C.: National Academy Press; 1990.
45. U.S. Department of Health and Human Services (SAMHSA, CSAT) Preliminary Report: The Persistent Effects of Substance Abuse Treatment One Year Later. Rockville: 1996. National Treatment Improvement Evaluation Study (NTIES)
46. Messina N, Wish E, Nemes S. Predictors of treatment outcomes in men and women admitted to a therapeutic community. American Journal of Drug and Alcohol Abuse. 2000;26:207–227. [PubMed] 47. Orlando M, Wenzel SL, Ebener P, Edwards MC, Mandell W, Becker K. The dimensions of change in therapeutic community treatment instrument. Psychological Assessment. 2006;18:118–122. [PubMed] 48. Paddock SM, Edelen MO, Wenzel SL, Ebener P, Mandell W, Dahl J. Measuring changes in client-level treatment process in the therapeutic community with the dimensions of change instrument. American Journal of Drug and Alcohol Abuse. 2007;33:537–546. [PubMed]
49. Spiegelhalter DJ, Best NG, Carlin BP, van der Linde A. Bayesian measures of model complexity and fit (with discussion) Journal of the Royal Statistical Society, Series B. 2002;64:583–639.
50. Thomas A, O’Hara B, Ligges U, Sturtz S. Making BUGS open. R News. 2006;6:12–17.
52. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics. 1982;38:963–974. [PubMed]
53. Meyer MA, Booker JM. Eliciting and Analyzing Expert Judgment: A Practical Guide. Philadelphia, PA: SIAM; 2001. p. 169.
54. Morgan MG, Henrion M, Small M. Uncertainty: A Guide to Dealing with Uncertainty in Quantitative Risk and Policy Analysis. Cambridge, United Kingdom: Cambridge University Press; 1990.
55. O’Hagan A, Buck CE, Daneshkhah A, Eiser JE, Garthwaite PH, Jenkinson DJ, Oakley JE, Rakow T. Uncertain Judgements: Eliciting Expert Probabilities. New York: Wiley; 2007.
56. Matheson JE, Winkler RL. Scoring rules for continuous probability distributions. Management Science. 1976;22:1087–1096.
57. Garvey PR. Probability Methods for Cost Uncertainty Analysis: A Systems Engineering Perspective. New York: Marcel Dekker; 2000.
58. Leon AC, Demirtas H, Hedeker D. Bias reduction with an adjustment for participants’ intent to dropout of a randomized controlled clinical trial. Clinical Trials. 2007;4:540–547. [PubMed]